Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder
Clinical trial NCT03569475 · COMPLETED
Trial details
- NCT number
- NCT03569475
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-06
- Primary completion
- 2021-03-01
- Enrollment
- 501
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.